FTC OKs Stryker's $4B Wright Medical Deal, With Divestitures

By Julia Arciga (November 3, 2020, 4:09 PM EST) -- The Federal Trade Commission is requiring medical device company Stryker Corp. to divest all its ankle replacement and finger joint implant products before going forward with its slated $4 billion acquisition of rival Wright Medical Group NV, the agency said Tuesday, in an effort to quell antitrust concerns stemming from the proposed merger....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!